Longitudinal linear-epitope profiling of SLE identifies novel antigens associated with disease and disease activity
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Systemic lupus erythematosus (SLE) is characterized by diverse autoantibodies, yet established biomarkers capture only a fraction of autoreactivity. We profiled 1,268 plasma samples from 695 patients with SLE and 301 healthy controls using phage immunoprecipitation sequencing (PhIP-seq). Machine learning identified a reproducible autoreactivity signature that discriminated SLE from controls across two validation cohorts. SLE autoreactivities were enriched for RNA-binding proteins, while targets containing Basic Acidic Dipeptide repeat domains were associated with high disease activity. A YTHDF2-derived peptide was the most prevalent shared autoreactivity, occurring in ∼25% of patients and exhibiting sequence similarity to Epstein-Barr virus (EBV) lytic switch protein BZLF1. Competition assays demonstrated higher-affinity binding to the viral peptide, consistent with EBV-associated molecular mimicry. Orthogonal validation using a 10-peptide Luminex panel strongly discriminated SLE from healthy controls. These findings expand the SLE autoantibody landscape, identify disease activity associated autoreactivities and insight linking EBV-driven immunity to epitope-specific autoimmunity in lupus.